155 related articles for article (PubMed ID: 22458903)
1. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?
Shen SS; Truong LD; Scarpelli M; Lopez-Beltran A
Arch Pathol Lab Med; 2012 Apr; 136(4):410-7. PubMed ID: 22458903
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
3. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
He H; Zhou GX; Zhou M; Chen L
Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
Zhou M; Roma A; Magi-Galluzzi C
Clin Lab Med; 2005 Jun; 25(2):247-57. PubMed ID: 15848735
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma with clear cell and papillary features.
Ross H; Martignoni G; Argani P
Arch Pathol Lab Med; 2012 Apr; 136(4):391-9. PubMed ID: 22458901
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
7. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
8. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
11. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
[TBL] [Abstract][Full Text] [Related]
12. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.
Baker PM; Oliva E
Int J Gynecol Pathol; 2005 Jan; 24(1):39-55. PubMed ID: 15626916
[TBL] [Abstract][Full Text] [Related]
15. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
Kobayashi N; Matsuzaki O; Shirai S; Aoki I; Yao M; Nagashima Y
Hum Pathol; 2008 Sep; 39(9):1350-9. PubMed ID: 18602672
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature.
Varma M; Jasani B
Histopathology; 2005 Jul; 47(1):1-16. PubMed ID: 15982318
[TBL] [Abstract][Full Text] [Related]
17. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
Browning L; Bailey D; Parker A
J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]